Zobrazeno 1 - 10
of 2 515
pro vyhledávání: '"Tawbi, H."'
Autor:
Long GV; Melanoma Institute Australia, The University of Sydney, Royal North Shore and Mater Hospitals, Sydney, NSW, Australia., Lipson EJ; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD., Hodi FS; Dana-Farber Cancer Institute, Boston, MA., Ascierto PA; Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Larkin J; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Lao C; University of Michigan, Ann Arbor, MI., Grob JJ; Aix-Marseille University, Hôpital de la Timone, Marseille, France., Ejzykowicz F; Bristol Myers Squibb, Princeton, NJ., Moshyk A; Bristol Myers Squibb, Princeton, NJ., Garcia-Horton V; Analysis Group, Inc, Boston, MA., Zhou ZY; Analysis Group, Inc, Boston, MA., Xin Y; Analysis Group, Inc, Boston, MA., Palaia J; Bristol Myers Squibb, Princeton, NJ., McDonald L; Bristol Myers Squibb, Princeton, NJ., Keidel S; Bristol Myers Squibb, Princeton, NJ., Salvatore A; Bristol Myers Squibb, Princeton, NJ., Patel D; Bristol Myers Squibb, Princeton, NJ., Sakkal LA; Bristol Myers Squibb, Princeton, NJ., Tawbi H; The University of Texas MD Anderson Cancer Center, Houston, TX., Schadendorf D; University of Essen and the German Cancer Consortium, Partner Site, Essen, Germany.; National Center for Tumor Diseases (NCT-West), Campus Essen, Essen, Germany.; University Alliance Ruhr, Research Center One Health, University Duisburg-Essen, Essen, Germany.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Nov 20; Vol. 42 (33), pp. 3926-3934. Date of Electronic Publication: 2024 Aug 13.
Autor:
Lopez-Olivo MA; Department of Health Services Research, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States., Suarez-Almazor ME; Department of Health Services Research, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States.; Section of Rheumatology and Clinical Immunology of the Department of General Internal Medicine, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States., Duhon GF; OCHIN, Inc, Portland, OR, United States., Cherry M; Texas Woman's University, Houston, TX, United States., Lu H; Section of Rheumatology and Clinical Immunology of the Department of General Internal Medicine, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States., Calabrese C; Department of Rheumatologic & Immunologic Disease, Cleveland Clinic, Cleveland, TX, United States., Altan M; Department of Thoracic-Head & Neck Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States., Tawbi H; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States., Meara A; Division of Internal Medicine, Wexner Medical Center, Ohio State University, Columbus, OH, United States., Bingham CO; Division of Rheumatology, Department of Medicine, Johns Hopkins University, Baltimore, MD, United States., Diab A; Department of Melanoma Medical Oncology, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States., Leal VB; Department of Health Services Research, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States., Volk RJ; Department of Health Services Research, MD Anderson Cancer Center, The University of Texas, Houston, TX, United States.
Publikováno v:
JMIR cancer [JMIR Cancer] 2024 Oct 25; Vol. 10, pp. e53443. Date of Electronic Publication: 2024 Oct 25.
Autor:
Turcios Escobar S; Department of Pathology, University of Illinois Hospital & Health Sciences System, Chicago, Illinois, USA., Yang R; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nelson KC; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gershenwald JE; Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Aung PP; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Torres-Cabala CA; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Journal of cutaneous pathology [J Cutan Pathol] 2024 Sep; Vol. 51 (9), pp. 644-648. Date of Electronic Publication: 2024 May 16.
Autor:
Le Rhun E; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Weller M; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Anders C; Duke Cancer Institute, Durham, United Kingdom., Larkin J; The Royal Marsden NHS Foundation Trust, London, United Kingdom., Li J; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA., Moss NS; Department of Neurosurgery and Brain Metastasis Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tawbi H; Department of Melanoma Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Dummer R; Department of Dermatology, University Hospital and University of Zurich, Zurich, Switzerland. Electronic address: Reinhard.Dummer@usz.ch.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2024 Sep; Vol. 208, pp. 114202. Date of Electronic Publication: 2024 Jul 06.
Autor:
Michielin, O., van Akkooi, A., Lorigan, P., Ascierto, P.A., Dummer, R., Robert, C., Arance, A., Blank, C.U., Chiarion Sileni, V., Donia, M., Faries, M.B., Gaudy-Marqueste, C., Gogas, H., Grob, J.J., Guckenberger, M., Haanen, J., Hayes, A.J., Hoeller, C., Lebbé, C., Lugowska, I., Mandalà, M., Márquez-Rodas, I., Nathan, P., Neyns, B., Olofsson Bagge, R., Puig, S., Rutkowski, P., Schilling, B., Sondak, V.K., Tawbi, H., Testori, A., Keilholz, U.
Publikováno v:
In Annals of Oncology November 2020 31(11):1449-1461
Autor:
Keilholz, U., Ascierto, P.A., Dummer, R., Robert, C., Lorigan, P., van Akkooi, A., Arance, A., Blank, C.U., Chiarion Sileni, V., Donia, M., Faries, M.B., Gaudy-Marqueste, C., Gogas, H., Grob, J.J., Guckenberger, M., Haanen, J., Hayes, A.J., Hoeller, C., Lebbé, C., Lugowska, I., Mandalà, M., Márquez-Rodas, I., Nathan, P., Neyns, B., Olofsson Bagge, R., Puig, S., Rutkowski, P., Schilling, B., Sondak, V.K., Tawbi, H., Testori, A., Michielin, O.
Publikováno v:
In Annals of Oncology November 2020 31(11):1435-1448
Autor:
Pellerino A; Division of Neuro-Oncology, Department of Neuroscience 'Rita Levi Montalcini', University and City of Health and Science Hospital, 10126 Turin, Italy., Davidson TM; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA., Bellur SS; Department of Medical Oncology, Miami Cancer Institute, Miami, FL 33176, USA., Ahluwalia MS; Department of Medical Oncology, Miami Cancer Institute, Miami, FL 33176, USA., Tawbi H; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, TX 77030, USA., Rudà R; Division of Neuro-Oncology, Department of Neuroscience 'Rita Levi Montalcini', University and City of Health and Science Hospital, 10126 Turin, Italy., Soffietti R; Candiolo Cancer Institute, FPO-IRCCS, 10060 Candiolo, Italy.
Publikováno v:
Cancers [Cancers (Basel)] 2024 Jun 04; Vol. 16 (11). Date of Electronic Publication: 2024 Jun 04.
Autor:
Gopalakrishnan, V., Spencer, C. N., Nezi, L., Reuben, A., Andrews, M. C., Karpinets, T. V., Prieto, P. A., Vicente, D., Hoffman, K., Wei, S. C., Cogdill, A. P., Zhao, L., Hudgens, C. W., Hutchinson, D. S., Manzo, T., de Macedo, M. Petaccia, Cotechini, T., Kumar, T., Chen, W. S., Reddy, S. M., Sloane, R. Szczepaniak, Galloway-Pena, J., Jiang, H., Chen, P. L., Shpall, E. J., Rezvani, K., Alousi, A. M., Chemaly, R. F., Shelburne, S., Vence, L. M., Okhuysen, P. C., Jensen, V. B., Swennes, A. G., McAllister, F., Sanchez, E. Marcelo Riquelme, Zhang, Y., Le Chatelier, E., Zitvogel, L., Pons, N., Austin-Breneman, J. L., Haydu, L. E., Burton, E. M., Gardner, J. M., Sirmans, E., Hu, J., Lazar, A. J., Tsujikawa, T., Diab, A., Tawbi, H., Glitza, I. C., Hwu, W. J., Patel, S. P., Woodman, S. E., Amaria, R. N., Davies, M. A., Gershenwald, J. E., Hwu, P., Lee, J. E., Zhang, J., Coussens, L. M., Cooper, Z. A., Futreal, P. A., Daniel, C. R., Ajami, N. J., Petrosino, J. F., Tetzlaff, M. T., Sharma, P., Allison, J. P., Jenq, R. R., Wargo, J. A.
Publikováno v:
Science, 2018 Jan 01. 359(6371), 97-103.
Externí odkaz:
https://www.jstor.org/stable/26401214
Autor:
Saberian C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Milton DR; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Simon J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Amaria RN; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Diab A; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McQuade J; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Patel SP; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Tawbi H; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Yee C; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wong MK; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McCutcheon IE; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Davies MA; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ferguson SD; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Glitza Oliva IC; Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Neuro-oncology practice [Neurooncol Pract] 2024 Mar 30; Vol. 11 (4), pp. 452-463. Date of Electronic Publication: 2024 Mar 30 (Print Publication: 2024).
Autor:
Menzies AM; Melanoma Institute Australia, NSW, Australia, and The University of Sydney, Sydney, Australia.; Royal North Shore and Mater Hospitals, The University of Sydney, Sydney, Australia., Long GV; Melanoma Institute Australia, NSW, Australia, and The University of Sydney, Sydney, Australia.; Royal North Shore and Mater Hospitals, The University of Sydney, Sydney, Australia., Kohn A; Division of Hematology/Medical Oncology, School of Medicine, Oregon Health Sciences University, Portland, Oregon, USA., Tawbi H; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Weber J; Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, New York, New York, USA., Flaherty K; Massachusetts General Cancer Center, Massachusetts General Hospital, Boston, Massachusetts, USA., McArthur GA; Sir Peter MacCallum Department of Oncology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Victoria, Australia., Ascierto PA; Unit of Melanoma Cancer Immunotherapy and Development Therapeutics, Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli, Italy., Pfluger Y; Alexander Fleming Institute, Buenos Aires, Argentina., Lewis K; Medical Oncology, University of Colorado, Health Center, Denver, Colorado, USA., Tsai KK; Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, California, USA., Hamid O; The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate Los Angeles, California, USA., Prenen H; Oncology Department, University Hospital Antwerp, Antwerp, Belgium., Fein L; Alexander Fleming Institute, Buenos Aires, Argentina., Wang E; Formerly Pfizer, New York, New York, USA., Guenzel C; Formerly Pfizer, New York, New York, USA., Zhang F; Formerly Pfizer, New York, New York, USA., Kleha JF; Formerly Pfizer, New York, New York, USA., di Pietro A; Pfizer Srl, Milan, Italy., Davies MA; Department of Melanoma Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Neuro-oncology advances [Neurooncol Adv] 2024 Mar 18; Vol. 6 (1), pp. vdae033. Date of Electronic Publication: 2024 Mar 18 (Print Publication: 2024).